NasdaqGS - Nasdaq Real Time Price USD

Outset Medical, Inc. (OM)

18.86
+0.07
+(0.40%)
As of 1:03:33 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Leslie L. Trigg President, CEO & Chairman 1.6M -- 1971
Mr. Nabeel Ahmed Chief Financial Officer 743.38k -- 1976
Mr. John L. Brottem J.D. General Counsel & Secretary 672.68k -- 1974
Mr. Marc Nash Senior Vice President of Operations and R&D -- -- 1989
Mr. James S. Mazzola Head of Investor Relations -- -- --
Ms. Laura Romike Senior Vice President of Sales -- -- --
Amelia Merrill VP of People Operations & Culture -- -- --
Dr. Michael Aragon M.D. Chief Medical Officer -- -- --
Ms. Jennifer Sipple Senior Vice President of Customer Experience -- -- --
Dinamarie Stefani Senior Vice President of Regulatory Affairs & Quality Assurance -- -- --

Outset Medical, Inc.

3052 Orchard Drive
San Jose, CA 95134
United States
669 231 8200 https://www.outsetmedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
354

Description

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Corporate Governance

Outset Medical, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 9. The pillar scores are Audit: 9; Board: 7; Shareholder Rights: 8; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 5, 2025 at 10:59 AM UTC - August 11, 2025 at 12:00 PM UTC

Outset Medical, Inc. Earnings Date

Recent Events

May 14, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 8, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 7, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 11, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 20, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 18, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 6, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 28, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 26, 2025 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

Related Tickers